Roche and CuraGen have announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in ...
CuraGen Corporation and Roche have announced that 454 Life Sciences and Roche have signed a definitive merger agreement under which Roche will acquire 454 Life Sciences Corporation, a majority-owned ...
High-throughput, next-generation sequencing instruments have dramatically accelerated the sequencing of genomes. The growth of this technology serves as an important milepost for the biomedical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback